secwatch.observer — SEC 8-K summary
======================================

Issuer:     BNB PLUS CORP. (BNBX)
CIK:        0000744452
Form:       8-K
Filed at:   2024-05-16T23:59:59+00:00
Accession:  0001104659-24-062618
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Applied DNA Sciences receives Nasdaq equity deficiency notice; equity negative $175K
--------------------------------------------------------------------------------

- As of March 31, 2024, stockholders' equity was negative $175,385, below the $2.5M minimum for Nasdaq Capital Market.
- Company must submit a compliance plan by July 1, 2024 to regain compliance with Nasdaq Listing Rule 5550(b)(1).
- Nasdaq may grant up to 180-day extension if plan accepted; no guarantee of acceptance or eventual compliance.
- Letter has no immediate effect on listing; company is evaluating options.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/744452/000110465924062618/0001104659-24-062618-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/744452/000110465924062618/tm2414775d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-062618

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer